Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Depression in the Elderly
1
x
$
30.00
VOL 2 No. 6 Full Issue - June 2000
1
x
$
20.00
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
1
x
$
30.00
Novel Mechanisms in the Future of Cancer Treatment: Angiogenesis & Signal Transduction
1
x
$
10.00
One Hundred Courses of Cluster Maintenance Transcranial Magnetic Stimulation (CM TMS)—A Clinical Audit Study
1
x
$
30.00
Advancing the Treatment of Mood and Anxiety Disorders: The First 10 Years’ Experience with Paroxetine
1
x
$
30.00
The Impact of Completing Medication Reconciliation and Depression Treatment History in an Outpatient Depression Clinic
1
x
$
30.00
Algorithms in Clinical Psychiatry: A Stepped Approach Toward the Path to Recovery
1
x
$
30.00
Efficacy of High-Dose Aripiprazole for Treatment-Resistant Schizoaffective Disorder: A Case Report
1
x
$
30.00
Federica Tozzi, MD: Candidate Gene Studies in Eating Disorders
1
x
$
30.00
Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder
1
x
$
30.00
View Cart
Checkout
Home
Store
“Revisiting Lithium: Utility for Behavioral Stabilization in Adolescents and Adults with Autism Spectrum Disorder” has been added to your cart.
View cart
Sort by
Price
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder
$
0.00
Add to cart
Details
Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects
$
0.00
Add to cart
Details
Metabolic and Endocrine Profiles During 1-Year Treatment of Outpatients with Schizophrenia with Aripiprazole Lauroxil
$
0.00
Add to cart
Details
A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
$
0.00
Add to cart
Details
VOL 47 No. 3 Table of Contents
$
0.00
Add to cart
Details
Rating Scales and Safety Measurements in Bipolar Disorder and Schizophrenia – A Reference Guide
$
0.00
Add to cart
Details
Brief Psychiatric Rating Scale by Psychopharmacology Bulletin
$
0.00
Add to cart
Details
Geriatric Depression Scale (Short Form)
$
0.00
Add to cart
Details
Efficacy of Low-Dose Aripiprazole for Treatment of Psychotic Symptoms in a Patient with 22q11.2 Deletion Syndrome (OPEN ACCESS)
$
0.00
Add to cart
Details
Spontaneous Ejaculation Induced with Atomoxetine (OPEN ACCESS)
$
0.00
Add to cart
Details
Carotid Artery Dissection Induced Acute Tongue Swelling in a Cocaine User (OPEN ACCESS)
$
0.00
Add to cart
Details
Misdiagnosis of Catatonia (OPEN ACCESS)
$
0.00
Add to cart
Details
Case Report: A Case of Intellectual Disability with Inappropriate and Challenging Sexual Behavior that was Treated with GNRH Analogues (OPEN ACCESS)
$
0.00
Add to cart
Details
ASD with the Bor Syndrome: A Case Report (OPEN ACCESS)
$
0.00
Add to cart
Details
Antiepileptic Drugs and Bone Health: Current Concepts (OPEN ACCESS)
$
0.00
Add to cart
Details
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)
$
0.00
Add to cart
Details
Assesment of Risk Factors for Tardive Dyskinesia (OPEN ACCESS)
$
0.00
Add to cart
Details
Use of Clozapine in the General Hospital (OPEN ACCESS)
$
0.00
Add to cart
Details
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)
$
0.00
Add to cart
Details
Previous
1
…
9
10
11
…
44
Next
Page load link
Go to Top
